H. Lv

发表

Activation of Alternate Prosurvival Pathways Accounts for Acquired Sunitinib Resistance in U87MG Glioma Xenografts

Amin R. Mazloom, Avi Ma’ayan, Huilei Xu, 2012, Journal of Pharmacology and Experimental Therapeutics.

Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents.

E. Reddy, J. Gallo, M. Reddy, 2013, Journal of medicinal chemistry.

Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma.

J. Gallo, Jyoti Sharma, Hua Lv, 2013, Cancer research.

Determination of pitavastatin in human plasma via HPLC-ESI-MS/MS and subsequent application to a clinical study in healthy Chinese volunteers.

Ying Zhang, Guang-Ji Wang, Yan Liang, 2007, Clinica chimica acta; international journal of clinical chemistry.

Quantitative analysis of 23-hydroxybetulinic acid, a novel anticancer substance, in the cellular environment of a human colon adenocarcinoma cell line for cellular pharmacokinetic studies.

W. Ye, Guangji Wang, Yan Liang, 2007, Rapid communications in mass spectrometry : RCM.

Sensitive and selective liquid chromatography-electrospray ionisation-mass spectrometry analysis of astragaloside-IV in rat plasma.

Guangji Wang, Hao Li, Jianguo Sun, 2006, Journal of pharmaceutical and biomedical analysis.

Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, Structure–Activity Relationship, and Selective Antitumor Activity

B. Zheng, Yongcheng Song, J. Gallo, 2014, Journal of medicinal chemistry.

Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats.

Guangji Wang, H. Hao, Yitong Liu, 2009, Journal of pharmaceutical sciences.

Screening candidate anticancer drugs for brain tumor chemotherapy: Pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues

E. Reddy, J. Gallo, Q. Zhou, 2012, Investigational New Drugs.

Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells.

Guang-Ji Wang, Hao Li, M. Roberts, 2005, Biological & pharmaceutical bulletin.

Simple, Sensitive and Rapid LC–ESI–MS Method for the Quantitation of Olprinone in Rat Plasma

Guangji Wang, Lin Xie, Yan Liang, 2007 .

Therapeutics , Targets , and Chemical Biology Intratumoral Modeling of Ge fi tinib Pharmacokinetics and Pharmacodynamics in an Orthotopic Mouse Model of Glioblastoma

J. Gallo, J. Sharma, H. Lv, 2013 .

Analytical approach to characterize the intratumoral pharmacokinetics and pharmacodynamics of gefitinib in a glioblastoma model.

J. Gallo, J. Sharma, H. Lv, 2012, Journal of Pharmacy and Science.

Absorption enhancement study of astragaloside IV based on its transport mechanism in Caco-2 cells

G. Wang, H. Xie, H. Lv, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Multiscale Design of Cell-Type–Specific Pharmacokinetic/Pharmacodynamic Models for Personalized Medicine: Application to Temozolomide in Brain Tumors

J. Gallo, J M Gallo, A. Ballesta, 2014, CPT: pharmacometrics & systems pharmacology.

Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models

J. Chipuk, J. Gallo, Q. Zhou, 2014, Molecular Cancer Therapeutics.

Preclinical Pharmacokinetic and Pharmacodynamic Evaluation of Novel Anticancer Agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for Brain Tumor Chemotherapy

James M. Gallo, E. Reddy, J. Gallo, 2012, Pharmaceutical Research.

Integrated Pharmacokinetic-Driven Approach to Screen Candidate Anticancer Drugs for Brain Tumor Chemotherapy

J. Gallo, M. Reddy, J. Sharma, 2012, The AAPS Journal.

Simultaneous determination of multiple angiotensin type 1 receptor antagonists and its application to high-throughput pharmacokinetic study

Guangji Wang, H. Hao, Xiao-ming Wu, 2008 .

Determination of ginsenoside Rd in dog plasma by liquid chromatography-mass spectrometry after solid-phase extraction and its application in dog pharmacokinetics studies.

Shuai Zhao, Guang-Ji Wang, Hao Li, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Identification of the major metabolites of 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichloridephenyl)-3H-1,2,4-triazol-3-one, a new angiotensin type 1 receptor antagonist, in rat bile by HPLC-diode array detection-MS and HPLC-MS/MS.

Guangji Wang, Xiao-ming Wu, Jinyi Xu, 2007, Biomedical chromatography : BMC.

Determination of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichloridephenyl)-3H-1,2,4-triazol-3-one, a New Angiotensin Type 1 Receptor Antagonist in Rat Plasma by LC-ESI-MS: Application to Pharmacokinetic Studies

Guangji Wang, Xiao-ming Wu, Jinyi Xu, 2007 .

Discovery of Pyrido[2,3-b]indole Derivatives with Gram-negative Activity Targeting Both DNA Gyrase and Topoisomerase IV.

Chengang Zhou, Zheng Zhou, Zhiheng Xu, 2020, Journal of medicinal chemistry.

Transport characteristics of ginkgolide B by Caco-2 cells and examination of ginkgolide B oral absorption potential using rat in situ intestinal loop method.

Guangji Wang, H. Hao, Lin Xie, 2008, International journal of pharmaceutics.

Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs

Guang-Ji Wang, Hao Li, R. Sun, 2012, European Journal of Drug Metabolism and Pharmacokinetics.

Preclinical Pharmacokinetic and Pharmacodynamic Evaluation of Novel Anticancer Agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for Brain Tumor Chemotherapy

J. Gallo, Q. Zhou, P. Guo, 2012, Pharmaceutical Research.

Simple, Sensitive, and Rapid LC–ESI-MS Method for Quantification of Mitiglinide in Human Urine

Guangji Wang, Lin Xie, Yan Liang, 2007 .

Integrated Pharmacokinetic-Driven Approach to Screen Candidate Anticancer Drugs for Brain Tumor Chemotherapy

J. Sharma, H. Lv, Xiaoping Zhang, 2012, The AAPS Journal.